InChI=1S/C18H34O5/c1- 2- 3- 7- 11- 16(20) 17(21) 14- 13- 15(19) 10- 8- 5- 4- 6- 9- 12- 18(22) 23/h13- 17,19- 21H,2- 12H2,1H3,(H,22,23) /b14- 13+/t15- ,16- ,17- /m0/s1 |
MDIUMSLCYIJBQC-MVFSOIOZSA-N |
CCCCC[C@H](O)[C@@H](O)\C=C\[C@@H](O)CCCCCCCC(O)=O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via TriHOME )
|
|
adjuvant
Any pharmacological or immunological agent that modifies the effect of other agents such as drugs or vaccines while having few if any direct effects when given by itself.
anti-inflammatory agent
Any compound that has anti-inflammatory effects.
|
|
View more via ChEBI Ontology
(9S,10E,12S,13S)-9,12,13-trihydroxyoctadec-10-enoic acid
|
(10E)-(9S,12S,13S)-9,12,13-Trihydroxyoctadec-10-enoic acid
|
KEGG COMPOUND
|
9(S),12(S),13(S)-Trihydroxy-10(E)-octadecenoic acid
|
KEGG COMPOUND
|
9,12,13-TriHOME
|
KEGG COMPOUND
|
9S,12S,13S-trihydroxy-10E-octadecenoic acid
|
LIPID MAPS
|
4317723
|
Reaxys Registry Number
|
Reaxys
|
97134-11-7
|
CAS Registry Number
|
Reaxys
|
12349955
|
PubMed citation
|
Europe PMC
|
12617925
|
PubMed citation
|
Europe PMC
|
15313433
|
PubMed citation
|
Europe PMC
|
20230917
|
PubMed citation
|
Europe PMC
|
21744276
|
PubMed citation
|
Europe PMC
|
23147809
|
PubMed citation
|
Europe PMC
|
|